12/27/2023 0 Comments Ved deviceBaseline measurements (SPL-1) were 10.71 ± 1.28 and 10.87 ± 1.26 cm in Group A and Group B, respectively and the day of surgery measurements (SPL-2) were 11.50 ± 1.33 and 11.06 ± 1.34 cm in Group A and Group B, respectively. Baseline patient characteristics, demographics, and comorbidities were the same in both groups. The surgeons performing the PP implantation (also blinded to the treatment assignments) provided subjective assessments of the ease of corporal dilatation. A research assistant (blinded to the treatment assignments) recorded SPL at baseline (initial consultation) and on day of surgery. Fifty-one patients scheduled for PP implantation for ED were randomized to either intervention group (pre-operative VED use 10–15 min/day for ≥30 days Group A n = 25), or control group (no intervention Group B n = 26). ![]() Therefore, the current randomized controlled study assessed two outcomes: whether pre-operative VED use for a month before surgery would significantly increase flaccid stretched penile length (SPL) on the day of surgery, and facilitate easier corporal dilatation intraoperatively. The preoperative use of vacuum erectile devices (VED) is an uncommon physical treatment for such concerns. In addition, corporal fibrosis is associated with difficult PP implantation. Patient concerns about penile length after penile prosthesis (PP) implantation for erectile dysfunction (ED) have significant impact on patients and their partners. In select cases such post-prostatectomy penile rehabilitation, as well as in men who cannot use a PDE5i, the vacuum device should be considered first-line treatment. The VED has continued to show efficacy for treatment of ED due to various etiologies and should be considered an attractive second-line therapy. Adverse events are transient and not serious. Early penile rehabilitation after surgery for prostate cancer with the VED appears to improve erectile function and penile length. Studies have demonstrated efficacy in ED associated with a variety of conditions. Review of the historical milestones, evolution, and modern utilization of VEDs in modern urological protocols. This article provides a detailed overview of the history of VEDs, a review of the literature, and a concise description of their new applications in modern urological practice.Ī retrospective review of publications relevant to the field of VEDs. More recently, this modality has been evaluated in initial phosphodiesterase inhibitor nonresponders as well as for post-prostatectomy penile rehabilitation. ![]() ![]() Studies have demonstrated efficacy in erectile dysfunction (ED) associated with a variety of conditions. Vacuum erection devices (VEDs) have been approved in the United States since 1982 and offer a viable alternative to oral phosphodiesterase type 5 inhibitors (PDE5i), injections and transurethral suppositories.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |